- DarioHealth (NASDAQ:DRIO): Q2 GAAP EPS of -$0.68 beats by $0.72.
- Revenue of $1.79M (+8.5% Y/Y) beats by $0.24M.
- Shares +1.9% PM.
- Press Release
- More news on: DarioHealth Corp., Earnings news and commentary, Stocks on the move, Tech stocks news, ,
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, has announced that two employers, a national supply chain company and a regional education organization, have selected its integrated chronic condition management solutions. According to the announcement, beginning in the ...
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution PR Newswire Dario selected to provide integrated and proven solutions to improve employee cardiometabolic health NEW YORK , April 18, 2024 /PRNewswire/ -- DarioHealth Corp....
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, has published two studies in the leading peer-reviewed journal for digital health and medicine, the “Journal of Internet Medicine. ” The studies include a randomized controlled trial (“RCT”) de...